Methotrexate Sodium Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Methotrexate Sodium Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 03/13/2023.

Shortage Details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-123-10
Dosage Form
Injection
Presentation
Methotrexate Sodium, Injection, 25 mg/1 mL (NDC 63323-123-10)
Initial Posting
03/13/2023
Revised Date